April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Systemic Co-Morbidity in Patients Undergoing Diabetic Vitrectomy
Author Affiliations & Notes
  • N. Vashisht
    Uvea & Vitreo-retina Services, DR R P Centre For Ophthalmic Sciences, Delhi, India
  • P. Venkatesh
    Uvea & Vitreo-Retina Services, DR R P Centre for Ophthalmic Sciences, Delhi, India
  • P. Naithani
    Uvea & Vitreo-Retina Services, DR R P Centre for Ophthalmic Sciences, Delhi, India
  • S. Khanduja
    Uvea & Vitreo-Retina Services, DR R P Centre for Ophthalmic Sciences, Delhi, India
  • S. Sinha
    Uvea & Vitreo-Retina Services, DR R P Centre for Ophthalmic Sciences, Delhi, India
  • S. Garg
    Uvea & Vitreo-Retina Services, DR R P Centre for Ophthalmic Sciences, Delhi, India
  • Footnotes
    Commercial Relationships  N. Vashisht, None; P. Venkatesh, None; P. Naithani, None; S. Khanduja, None; S. Sinha, None; S. Garg, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2081. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Vashisht, P. Venkatesh, P. Naithani, S. Khanduja, S. Sinha, S. Garg; Systemic Co-Morbidity in Patients Undergoing Diabetic Vitrectomy. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2081.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To study the systemic co-morbidity factors in patients undergoing diabetic vitrectomy & its co-relation with severity of diabetic eye disease (DED).

Methods: : In this retrospective study records of 100 patients with diabetes mellitus (DM) who underwent parsplana vitrectomy (PPV) were reviewed. All the patients underwent thorough systemic clinical examination. The following systemic co-morbidity factors were evaluated hypertension (HTN), ischemic heart disease (IHD), cerebrovascular accidents (CVA), hyperlipidemia (HYL), diabetic nephropathy (DNP), diabetic neuropathy (DNU) & diabetic foot (DF). The sent laboratory investigations (blood & urine) were also reviewed.The data was analyzed with respect to the incidence of systemic co-morbidity in these patients & the possible correlation with respect to disease severity.

Results: : There were 62 males & 38 females with mean age of 56.3 years. The mean duration of DM was 13.2years & there were 89 patients with insulin-dependent DM (IDDM) & 11 with non-IDDM. 95 patients had proliferative diabetic retinopathy.The indications for PPV were vitreous haemorrhage-54, diabetic tractional detachment-30, vitreomacular traction-9, combined retinal detachment-4 & neovascular glaucoma-3 . The following was the incidence of co-morbidities HTN-71, DNP-67, HYL-45, IHD-33, DNU-27, CVA-19, DF-15 & foot amputation-8. Amongst the co-morbidity factors, the severity of DED in the non-operated eye (in terms of visual acuity and macular edema) correlated well with poor hypertension control and worse DNP.

Conclusions: : Ophthalmologist should exert proper attention to systemic profile in diabetic population. The need of team work is stressed in appropriate management of diabetes mellitus. Adequate renal status and hypertension control could prevent worsening of DED.

Keywords: diabetes • vitreoretinal surgery • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×